Harvest Portfolios Group Inc. Has $64.03 Million Stock Holdings in Danaher Corporation $DHR

Harvest Portfolios Group Inc. cut its stake in shares of Danaher Corporation (NYSE:DHRFree Report) by 4.4% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 279,688 shares of the conglomerate’s stock after selling 12,867 shares during the period. Danaher makes up about 1.1% of Harvest Portfolios Group Inc.’s holdings, making the stock its 24th biggest position. Harvest Portfolios Group Inc.’s holdings in Danaher were worth $64,026,000 as of its most recent SEC filing.

Several other hedge funds have also made changes to their positions in DHR. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the 3rd quarter valued at approximately $25,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher in the 4th quarter valued at approximately $26,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the 2nd quarter valued at approximately $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the 3rd quarter worth about $27,000. Finally, Financial Life Planners acquired a new stake in Danaher during the 3rd quarter worth about $32,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the transaction, the executive vice president owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Corporate insiders own 10.80% of the company’s stock.

Danaher Trading Up 1.9%

Danaher stock opened at $166.97 on Wednesday. The company’s fifty day simple moving average is $184.97 and its 200-day simple moving average is $209.60. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a market cap of $118.18 billion, a P/E ratio of 32.30, a P/E/G ratio of 2.19 and a beta of 0.81.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings data on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the company posted $1.88 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. As a group, sell-side analysts forecast that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be issued a $0.40 dividend. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a yield of 1.0%. Danaher’s dividend payout ratio is currently 30.95%.

Analyst Ratings Changes

A number of equities research analysts have commented on the company. Jefferies Financial Group restated a “buy” rating and set a $245.00 price objective on shares of Danaher in a research report on Tuesday, April 21st. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a research report on Thursday, January 29th. The Goldman Sachs Group decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Argus decreased their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research report on Friday, March 27th. Nineteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $238.65.

Check Out Our Latest Report on DHR

Danaher Company Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.